Low-cost biosensing methods are crucial for the early detection of diseases. The work presents a smartphone-based detection scheme based on two asymmetrically evaporated droplets on a nanofibrous membrane with the specimen sample and plasmonic nanoparticles, respectively. Leveraging deep learning algorithms, we achieve automatic detection and quantification of a range of proteins based on distinct droplet patterns to differentiate positive/negative cases, including N-protein, PCT, CEA, and PSA at concentrations as low as 10 pg/ml in 12 minutes. The method enhances the droplet pre-concentration and the generation of optically structural patterns via plasmonic particles for improved sensing sensitivity.
No takes yet. Share an insight, caveat, or question.
Behrouzi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: